Singapore General Hospital enters into a joint research and development agreement with Nanyang Technological University in order to develop customized medical devices and implants utilizing 3D printing

Latest Biopharmaceutical Industry Developments

On 04 December 2023, Singapore General Hospital (SGH) patients stand to gain from advancements in healthcare through the collaboration between Nanyang Technological University, Singapore (NTU Singapore), and the establishment of a Joint Research & Development Laboratory in additive manufacturing (AM) – also known as 3D printing.

These ongoing innovations signify a significant stride towards pioneering healthcare solutions that have the potential to redefine patient care. The partnership harnesses the collective expertise and resources of SGH's 3D Printing Centre and NTU's Singapore Centre for 3D Printing  to explore and advance technologies relevant to clinical applications in a point-of-care setting.

The Joint R&D Lab in additive manufacturing will concentrate on four key areas:

• Development of Prosthetic & Orthotic Devices
• Advancements in Bioprinting for Regenerative Medicine
• Creation of 3D Printed Implants at the Point-of-Care
• Exploration and Analysis of Additive Manufacturing Technology for Healthcare Applications

According to Roots Analysis, 3D Bioprinting Market size is anticipated to grow at a exponential rate during the coming years.

For detailed insights about this domain, check out our report on 3D Bioprinting Market or email sales@rootsanalysis.com